"Mitolactol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs.
MeSH Number(s)
D02.033.800.400.500
D09.853.400.500
Below are MeSH descriptors whose meaning is more general than "Mitolactol".
Below are MeSH descriptors whose meaning is more specific than "Mitolactol".
This graph shows the total number of publications written about "Mitolactol" by people in Harvard Catalyst Profiles by year, and whether "Mitolactol" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1998 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
Below are the most recent publications written about "Mitolactol" by people in Profiles.
-
Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update. J Neurooncol. 2010 Oct; 100(1):121-7.
-
Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421. Blood. 2006 Feb 15; 107(4):1315-24.
-
Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181). Am J Clin Oncol. 1998 Feb; 21(1):99-104.
-
Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer. J Clin Oncol. 1994 Apr; 12(4):874-5.
-
Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 1994 Jan; 12(1):45-9.
-
Metastatic breast cancer: higher versus low dose maintenance treatment when only a partial response or a no change status is obtained following doxorubicin induction treatment. An Eastern Cooperative Oncology Group study. Ann Oncol. 1992 Nov; 3(9):768-70.
-
Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. J Clin Oncol. 1991 Dec; 9(12):2153-61.
-
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer. Am J Clin Oncol. 1991 Feb; 14(1):45-8.
-
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer. J Clin Oncol. 1989 Sep; 7(9):1252-9.
-
A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients. Am J Clin Oncol. 1988 Dec; 11(6):666-8.